Cirrhotic cardiomyopathy
Mauro Bernardi – 21 June 2013 – Watch a video presentation of this article
Cirrhotic cardiomyopathy
Mauro Bernardi – 21 June 2013 – Watch a video presentation of this article
Prospective, randomized study of ropivacaine wound infusion versus intrathecal morphine with intravenous fentanyl for analgesia in living donors for liver transplantation
Sang Hyun Lee, Mi Sook Gwak, Soo Joo Choi, Hui Gyeong Park, Gaab Soo Kim, Myung Hee Kim, Hyun Joo Ahn, Jieae Kim, Choon Hyuck Kwon, Tae Seok Kim – 21 June 2013 – Postoperative analgesia and care for living liver donors have become particular interests for clinicians as the use of living donor liver transplantation has increased. Local anesthetic–based analgesia has been known to provide effective pain control.
Acute‐on‐chronic liver failure: Is the definition ready for prime time?
Richard Moreau, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article
Hypervolemic hyponatremia: Clinical significance and management
Brett E. Fortune, Guadalupe Garcia‐Tsao – 21 June 2013 – Watch a video presentation of this article
Bacterial infections in cirrhosis: A growing problem with significant implications
Javier Fernandez, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article
Workup of nonalcoholic fatty liver disease
Shih‐Wei Lai, Kuan‐Fu Liao – 21 June 2013 – Watch a video presentation of this article
Acute‐on‐chronic liver failure: Is the definition ready for prime time?
Richard Moreau, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article
Bacterial infections in cirrhosis: A growing problem with significant implications
Javier Fernandez, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article
Living related liver transplantation for hepatitis B–related liver disease without hepatitis B immune globulin prophylaxis
Manav Wadhawan, Subash Gupta, Neerav Goyal, Sunil Taneja, Ajay Kumar – 21 June 2013 – Hepatitis B immune globulin (HBIG) is routinely used in liver transplantation for hepatitis B virus (HBV)–related liver disease. With potent oral antivirals, HBIG may not be required. We conducted a prospective trial to evaluate living related liver transplantation (LRLT) without HBIG. Eighty‐nine patients with HBV‐related liver disease underwent LRLT between January 2005 and January 2012. All donors were vaccinated with the HBV vaccine.